{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:36:11Z","timestamp":1792654571346,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG029824"],"award-info":[{"award-number":["U01AG029824"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG062682"],"award-info":[{"award-number":["U19AG062682"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1127060"],"award-info":[{"award-number":["1127060"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["334047"],"award-info":[{"award-number":["334047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cct.2023.107231","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T17:22:18Z","timestamp":1684171338000},"page":"107231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly \u2013 eXTension (ASPREE-XT) Observational Study"],"prefix":"10.1016","volume":"130","author":[{"given":"Michael E.","family":"Ernst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj C.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Kirpach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2023.107231_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","author":"US Preventive Services Task Force","year":"2022","journal-title":"JAMA."},{"key":"10.1016\/j.cct.2023.107231_bb0010","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.cct.2023.107231_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107231_bb0020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.cct.2023.107231_bb0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","volume":"379","author":"Bowman","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cct.2023.107231_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12210","article-title":"Use of preventive Aspirin among older US adults with and without diabetes","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cct.2023.107231_bb0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/M19-0953","article-title":"Prevalence of Aspirin use for primary prevention of cardiovascular disease in the United States: results from the 2017 National Health Interview Survey","volume":"171","author":"O\u2019Brien","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2023.107231_bb0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US preventive services task force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2023.107231_bb0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.cct.2023.107231_bb0050","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/gerona\/glw342","article-title":"Baseline characteristics of participants in the ASPREE (Aspirin in reducing events in the elderly) study","volume":"72","author":"McNeil","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.cct.2023.107231_bb0055","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/s41436-020-0881-7","article-title":"Medically actionable pathogenic variants in a population of 13,131 health elderly individuals","volume":"22","author":"Lacaze","year":"2020","journal-title":"Genet Med."},{"key":"10.1016\/j.cct.2023.107231_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyy279","article-title":"Cohort profile: the ASPREE longitudinal study of older persons (ALSOP)","volume":"48","author":"McNeil","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cct.2023.107231_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1747493016669848","volume":"12","author":"Ward","year":"2017","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.cct.2023.107231_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/injuryprev-2015-041655","article-title":"A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-fracture substudy","volume":"22","author":"Barker","year":"2016","journal-title":"Injury Prevent."},{"key":"10.1016\/j.cct.2023.107231_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.conctc.2017.03.005","article-title":"Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: rationale and study design of the ASPREE-AMD study","volume":"6","author":"Robman","year":"2017","journal-title":"Contemp. Clin. Trials Communic."},{"key":"10.1016\/j.cct.2023.107231_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cct.2015.11.014","article-title":"Slowing the progression of age-related hearing loss: rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial","volume":"46","author":"Lowthian","year":"2016","journal-title":"Contemp. Clin. Trial."},{"key":"10.1016\/j.cct.2023.107231_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2377-12-3","article-title":"Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)","volume":"12","author":"Reid","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.cct.2023.107231_bb0090","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"JJ","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107231_bb0095","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"JJ","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cct.2023.107231_bb0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13063-018-2653-0","article-title":"Post-trial follow-up methodology in large randomised controlled trials: a systematic review","volume":"19","author":"Llewellyn-Bennett","year":"2018","journal-title":"Trials."},{"issue":"12","key":"10.1016\/j.cct.2023.107231_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226868","article-title":"Optimising medication data collection in a large-scale clinical trial","volume":"14","author":"Lockery","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cct.2023.107231_bb0110","article-title":"Aspirin and the USPSTF\u2014what about Cancer?","author":"Chan","year":"2022","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.cct.2023.107231_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13063-017-2394-5","article-title":"Routinely collected data for randomized trials: promises, barriers, and implications","volume":"19","author":"Mc Cord","year":"2018","journal-title":"Trials."},{"issue":"8","key":"10.1016\/j.cct.2023.107231_bb0120","article-title":"Aspirin for cardiovascular disease prevention among adults in the United States: trends, prevalence, and participant characteristics associated with use","volume":"22","author":"Boakye","year":"2021","journal-title":"Am J. Prev. Cardiol."},{"issue":"12","key":"10.1016\/j.cct.2023.107231_bb0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J. R. Soc. Med."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:59:18Z","timestamp":1761555558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714423001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":25,"alternative-id":["S1551714423001544"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2023.107231","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly \u2013 eXTension (ASPREE-XT) Observational Study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2023.107231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107231"}}